Annual Current Ratio
10.79
+1.37+14.54%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual current ratio is currently 10.79, with the most recent change of +1.37 (+14.54%) on 31 December 2023. During the last 3 years, it has fallen by -8.62 (-44.41%). PRLD annual current ratio is now -44.41% below its all-time high of 19.41, reached on 31 December 2020.PRLD Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
7.04
-0.79-10.09%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly current ratio is currently 7.04, with the most recent change of -0.79 (-10.09%) on 30 September 2024. Over the past year, it has dropped by -6.87 (-49.39%). PRLD quarterly current ratio is now -76.04% below its all-time high of 29.38, reached on 31 March 2021.PRLD Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.5% | -49.4% |
| 3 y3 years | -44.4% | -57.5% |
| 5 y5 years | +69.4% | - |
PRLD Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -44.4% | +14.5% | -58.9% | at low |
| 5 y | 5 years | -44.4% | +158.1% | -76.0% | +68.4% |
| alltime | all time | -44.4% | +158.1% | -76.0% | +68.4% |
Prelude Therapeutics Incorporated Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 7.04(-10.1%) |
| June 2024 | - | 7.83(-32.7%) |
| Mar 2024 | - | 11.64(+7.9%) |
| Dec 2023 | 10.79(+14.5%) | 10.79(-22.4%) |
| Sept 2023 | - | 13.91(-18.8%) |
| June 2023 | - | 17.13(+92.3%) |
| Mar 2023 | - | 8.91(-5.4%) |
| Dec 2022 | 9.42 | 9.42(-10.5%) |
| Sept 2022 | - | 10.52(-33.1%) |
| June 2022 | - | 15.72(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 16.80(+9.3%) |
| Dec 2021 | 15.37(-20.8%) | 15.37(-7.2%) |
| Sept 2021 | - | 16.57(-29.4%) |
| June 2021 | - | 23.48(-20.1%) |
| Mar 2021 | - | 29.38(+51.4%) |
| Dec 2020 | 19.41(+364.4%) | 19.41(-7.4%) |
| Sept 2020 | - | 20.96(+285.3%) |
| June 2020 | - | 5.44(+30.1%) |
| Dec 2019 | 4.18(-34.4%) | 4.18 |
| Dec 2018 | 6.37 | - |
FAQ
- What is Prelude Therapeutics Incorporated annual current ratio?
- What is the all time high annual current ratio for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual current ratio year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly current ratio?
- What is the all time high quarterly current ratio for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly current ratio year-on-year change?
What is Prelude Therapeutics Incorporated annual current ratio?
The current annual current ratio of PRLD is 10.79
What is the all time high annual current ratio for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual current ratio is 19.41
What is Prelude Therapeutics Incorporated annual current ratio year-on-year change?
Over the past year, PRLD annual current ratio has changed by +1.37 (+14.54%)
What is Prelude Therapeutics Incorporated quarterly current ratio?
The current quarterly current ratio of PRLD is 7.04
What is the all time high quarterly current ratio for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly current ratio is 29.38
What is Prelude Therapeutics Incorporated quarterly current ratio year-on-year change?
Over the past year, PRLD quarterly current ratio has changed by -6.87 (-49.39%)